Study the robustness of supply chain and use of technology with respect to inventory, supply and consumption of medicines and medical consumables in 108 ambulances of EMRI ( about 10,000 in number spread in 13 states in India) and suggest improvement keeping following critical parameters as central focus of study:

- Inventory levels
- Stock outs
- Obsolescence
- Leakage/ pilferage
- Delivery system/ logistics
- Cost of logistics

Follow up to last year with our Equitable Ann Arbor Land Trust agenda, www.ea2landtrust.org, goals to convert UM and City parking lots around campus into affordable, workforce and market rate housing. Goals are to add thousands of residents housing over neighborhood retail with 15 Minute Neighborhood characteristics, all needs within a 15 minute walk. Near jobs and transit ops to be highly sustainable and affordable.

Optimize Experian's global asset management process for laptop and desktop assets.

Evaluate our current load tendering and management platform that manages the end-to-end process of scheduling commitments. Provide recommendations to help streamline operations (assign loads sooner and on more of a schedule) and gain preferred pricing with vendors.

Provide an overall strategy for increasing delivery capacity and efficiency.

Develop a business plan to capture growth within a new healthcare market

Assess the impact of own fleet servicing infrastructure versus outsourced repair system. Study of EMRI fleet management automation framework, and identify opportunities for more efficient and timely ambulance repair and operations.

Develop a business case for a suite of travel insurance products and services that will appeal to young travelers.

Evaluate our current load tendering and management platform that manages the end-to-end process of scheduling commitments. Provide recommendations to help streamline operations (assign loads sooner and on more of a schedule) and gain preferred pricing with vendors.

Develop a three-year, actionable corporate roadmap for Exxel Pharma to reach a partnership or out-licensing event, supported by key business metrics and primary research.

Assessment and comparison of pharmaceutical markets to guide lead indication selection and alliance-forming.

Optimize use of three global programs to increase pace of innovation and the quantity of new, high-valued products delivered to the market.

Streamline and automate an operations process using a combination of proven re-engineering techniques and leading-edge Robotic Process Automation (RPA) capabilities.